Skip to main content

Diagnostic Catheter Market: What Will be the Growth Scenario in the next five years?

 The overall diagnostic catheters market is projected to reach USD 4,302.3 million by 2021 from USD 3,025.8 million in 2016, at a CAGR of 7.3% from 2016 to 2021. Advancements in medical imaging technologies, increasing number of minimally invasive procedures, launch of new technologies in terms of catheter design, and rising geriatric population (resulting in a subsequent growth in the prevalence of chronic disorders) are primarily expected to drive growth in the global market. However, factors such as dearth of skilled professionals, high cost of technologically advanced catheters, and the trend of reusing single-use diagnostic catheters are expected to restrain market growth to a certain extent.

Growing preference of OCT imaging catheters in intravascular diagnostics and imaging:

OCT has revolutionized the medical imaging industry and has extended its applications in disease diagnosis and imaging of various cellular and molecular processes in vivo. The successful application of OCT imaging in various diagnostic areas such as cardiology has resulted in greater adoption of OCT imaging catheters by doctors for various diagnostic indications. The resolution limits of coronary angiography, along with the need for greater precision during percutaneous interventions have resulted in increased demand for high-resolution intracoronary imaging techniques such as OCT. These varied advantages of OCT imaging have drawn a number of market players to launch new OCT imaging systems and catheters for diagnostic applications. In October 2013, St. Jude Medical launched an OCT-assisted system for coronary imaging in the US.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=114053400

Major Market Developments:

In October 2015, Cardinal Health, Inc. acquired Johnson & Johnson's (U.S.) Cordis business, a global player in the cardiovascular and endovascular devices market. The acquisition enhanced Cardinal Health's portfolio of diagnostic catheters used in cardiology and endovascular applications, helping Cardinal Health to strengthen its position in the global market, specifically in the cardiovascular area.

In February 2015, Royal Philips (U.S.), a part of Koninklijke Philips N.V., acquired Volcano Corporation (U.S.), a global leader in intravascular imaging for coronary and peripheral therapeutic devices. This acquisition has helped the company to become a leading systems integrator in the fast-growing image-guided MIS market.

In October 2013, St. Jude Medical launched OCT-assisted system for coronary imaging in the U.S. This system uses St. Jude’s Dragonfly Duo Imaging catheter to capture near-infrared light. This launch has enhanced the company’s portfolio for advanced diagnostic catheters in the US market.

Know more in detail analysis of global Diagnostic Catheter Market :
https://www.marketsandmarkets.com/Market-Reports/diagnostic-catheter-market-114053400.html

Comments

Popular posts from this blog

NGS-Based RNA-Sequencing Industry is Growing at a CAGR of 20%

NGS-based RNA-sequencing Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market. NGS-based RNA-sequencing Market: Impact Analysis 1. NGS-Based RNA-Sequencing: Market Overview 2. Geographical Snapshot of the NGS-Based RNA-Sequencing Market 3. Rapid Growth in Precision Medicine 4. Growing Number of Research Activities Involving RNA-Seq 5. Increasing Applications of RNA-Seq in Research ( Cancer and Agricultural) The NGS-based RNA-sequencing market size is estimated to grow from USD 1.7 billion in 2019 to USD 4.2 billion by 2024, at a CAGR of 20.0%. Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global NGS-based RNA-sequencing market? 2. What are the drivers, restraints, opportunities, and challenges in the NGS-based RNA-sequencing Industry? 3. What are th...

Epigenetics Market | Major Market Dynamics Impacting The Global Industry

Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, by several factors including age, environment, disease state, and changes in lifestyle. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the epigenetics market in the coming years. The growth in this market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Epigenetic changes such as dysregulation of DNA methylation are associated with cancer development and progression. Epigenetics provides new opportunities for deriving therapeutic strateg...

Digital Diabetes Management Market to Reach $19.98 billion by 2024 | Market and Regional Growth Analysis

  Digital diabetes management solutions are smartphone-connected diabetes management devices and software platforms used by patients suffering from Type 1, Type 2, and gestational diabetes. Medical professionals also use these solutions to manage diabetes. Various digital diabetes management devices such as smart glucose meters, continuous glucose monitoring systems, smart insulin pens, and smart insulin pumps/closed-loop systems and smart insulin patches are used for glucose monitoring and insulin delivery. Diabetes management applications, data management software & platforms, and services are used by patients and healthcare providers for remote monitoring, data analysis, and disease management. The Digital Diabetes Management Market is experiencing significant growth due to rising prevalence of diabetes has increased the focus on the development and adoption of better solutions for diabetes care. Also, advancements in technologies have ensured the introduction of highly...